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Abstract
Background: Dietary fibre-induced satiety offers a physiological approach to body weight regulation, yet there is
lack of scientific evidence. This experiment quantified food intake, body weight and body composition responses to
three different soluble fermentable dietary fibres in an animal model and explored underlying mechanisms of
satiety signalling and hindgut fermentation.
Methods: Young adult male rats were fed ad libitum purified control diet (CONT) containing 5% w/w cellulose
(insoluble fibre), or diet containing 10% w/w cellulose (CELL), fructo-oligosaccharide (FOS), oat beta-glucan (GLUC)
or apple pectin (PECT) (4 weeks; n = 10/group). Food intake, body weight, and body composition (MRI) were
recorded, final blood samples analysed for gut satiety hormones, hindgut contents for fermentation products
(including short-chain fatty acids, SCFA) and intestinal tissues for SCFA receptor gene expression.
Results: GLUC, FOS and PECT groups had, respectively, 10% (P < 0.05), 17% (P < 0.001) and 19% (P < 0.001) lower
food intake and 37% (P < 0.01), 37% (P < 0.01) and 45% (P < 0.001) lower body weight gain than CONT during the
four-week experiment. At the end they had 26% (P < 0.05), 35% (P < 0.01) and 42% (P < 0.001) less total body fat,
respectively, while plasma total glucagon-like peptide-1 (GLP-1) was 2.2-, 3.2- and 2.6-fold higher (P < 0.001) and
peptide tyrosine tyrosine (PYY) was 2.3-, 3.1- and 3.0-fold higher (P < 0.001). There were no differences in these
parameters between CONT and CELL. Compared with CONT and CELL, caecal concentrations of fermentation
products increased 1.4- to 2.2-fold in GLUC, FOS and PECT (P < 0.05) and colonic concentrations increased 1.9- to
2.5-fold in GLUC and FOS (P < 0.05), with no consistent changes in SCFA receptor gene expression detected.
Conclusions: This provides animal model evidence that sustained intake of three different soluble dietary fibres
decreases food intake, weight gain and adiposity, increases circulating satiety hormones GLP-1 and PYY, and
increases hindgut fermentation. The presence of soluble fermentable fibre appears to be more important than its
source. The results suggest that dietary fibre-induced satiety is worthy of further investigation towards natural body
weight regulation in humans.
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There is growing interest in targeting increased satiety as
a potential countermeasure to the current global obesity
epidemic, often embracing pharmacological and surgical
approaches (eg [1-3]). However, an alternative physio-
logical approach is to use food constituents that naturally
increase satiety and reduce overall caloric intake. Dietary
fibre is one such food constituent variously associated with
decreasing appetite and body weight, but data from hu-
man trials remain equivocal [4-8]. This may be resolved in
the first instance using laboratory animals where there is
complete control over the diet and the opportunity to col-
lect gut tissue samples in which to explore underlying mo-
lecular mechanisms. Studies in rats and mice have indeed
shown that diets containing increased amounts of dietary
fibre result in lower body weight and/or adiposity; how-
ever, effects on food intake and satiety are inconsistent, in
part due to the variability in study designs, for example in
terms of fibre type, duration of feeding, dose rate, and age
and phenotype of the experimental animals [9-13]. Herein
the aim was to control for the variations found in previous
studies by quantifying responses to different types of sol-
uble dietary fibre within the same study, using a fixed dur-
ation of feeding, a fixed dose rate and conventional young
adult male rats. While results from this animal model may
not apply directly to solve the obesity epidemic in humans,
they may contribute to the scientific knowledge base lead-
ing towards that ultimate goal.
Dietary fibre is a general term describing indigestible
carbohydrates that can be broken down by bacterial fer-
mentation in the large intestine and includes insoluble
molecules such cellulose that are poorly fermented but
also soluble molecules that tend to be more highly fer-
mented [10,14,15]. This study utilised three commonly-
occurring yet contrasting types of soluble fermentable
dietary fibre, with cellulose included as an insoluble con-
trol fibre for comparison. Beta-glucan is a highly poly-
merised branch-structured glucose polysaccharide found
in cereals and bran, pectin is a highly polymerised galac-
turonic acid polysaccharide present in fruit and vegetables,
and fructo-oligosaccharide (FOS) is a fructose polymer
with a contrastingly low degree of polymerisation, present
in fruit and vegetables as well as in artificial sweeteners.
These soluble fibres also demonstrate different physico-
chemical attributes, for example pectin and beta-glucan
have high viscosity whereas FOS has negligible viscosity,
while all are highly fermentable [10,14,15]. Choice of these
fibres was influenced by existing evidence for responses to
their inclusion in diets for ad libitum-fed rats and mice in
a wide range of study designs. Thus dietary inclusion of
oat beta-glucan at 7% for 6 weeks decreased caloric intake
and there were trends towards decreased body weight gain
and decreased fat pad weights in adult diet-induced obese
mice [9] but given at 5% for 6 weeks had no effect on food
intake or body weight while decreasing epididymal fat pad
weights in growing rats [10]. Food intake and growth rate
were decreased in weanling rats given dietary pectin at 8%
for 14 days [11] whereas food intake increased and body
weight was unaffected in young rats given 5% pectin for
21 days in another unrelated study [12]; effects on body
composition were not reported in these studies. In grow-
ing rats, dietary inclusion of FOS at 10% for 3-4 weeks de-
creased food energy intake, body weight gain and adipose
tissue mass [13] but at 5% for 6 weeks in another study
only decreased epididymal fat pad mass without affecting
intake or body weight [10], while 6% of a similar carbohy-
drate type, galacto-oligosaccharide, in the diet for 3 weeks
also reduced epididymal fat-pad weight [16]. Guided by
these previous studies, the present study used normal out-
bred young adult rats, a standard dietary fibre inclusion
rate of 10% and a duration of 4 weeks to compare and
quantify intake, body weight and body composition re-
sponses to different soluble fibres for the first time within
the same study.
Several decades of research have identified the key role
played by gastrointestinal peptide hormones in the con-
trol of food intake and hunger/satiety [17]. Thus ghrelin
secreted from the stomach stimulates food intake while
cholecystokinin (CCK), peptide tyrosine tyrosine (PYY)
and glucagon-like peptide-1 (GLP-1) from the intestine
signal satiety and inhibit food intake [18]. It is postulated
that the satiating effects of dietary fibre are mediated at
least in part by these gut hormones since, for example,
FOS feeding is associated with increased circulating
GLP-1 and decreased ghrelin in rats [19] and oat beta
glucan increases PYY secretion in diet-induced obese
mice [9,20], but there are no reports on the effects of
dietary pectin on these gut hormones. Gut hormone se-
cretion was therefore assessed in our model from both
plasma concentrations (ghrelin, CCK, PYY and GLP-1)
and gut tissue gene expression (PYY and GLP-1). Since
these hormones are secreted by enteroendocrine cells
within the gut mucosa, it was also pertinent to investi-
gate how these cells sense the presence of dietary fibre
in the gut lumen. The products of dietary fibre fermen-
tation are organic acids, mainly the short-chain fatty
acids (SCFAs) acetate, propionate and butyrate, but also
others such as succinate and lactate [21]. The presence
of SCFA-activated receptors in colonic mucosa provides
grounds for implicating SCFA sensing in the stimulation
of gut satiety hormones [22]. Furthermore SCFA activa-
tion of free fatty acid receptors (ffar)2 and ffar3 has been
associated with stimulation of PYYand GLP-1 secretion in
human and rodent models [23-25]. The succinate receptor
(sucnr1) is also expressed in intestinal mucosa [26] but
has not been linked to gut hormone secretion. The present
study therefore examined in the animal model concentra-
tions of fermentation products (including SCFA) in the
Adam et al. Nutrition & Metabolism 2014, 11:36 Page 2 of 12
http://www.nutritionandmetabolism.com/content/11/1/36lower gut contents and gene expression for SCFA recep-
tors in the lower gut tissue.
This experiment investigated the hypothesis that sol-
uble dietary fibre from different sources decreases volun-
tary food intake, body weight and body fat mass in
normal healthy young adult male rats and that the in-
creased satiety may be brought about by increased
amounts of fermentation products in the lower gut sig-
nalling via SCFA-activated receptors to stimulate gut sa-
tiety hormone secretion. The article reports that these
soluble dietary fibres did indeed decrease food intake,
weight gain and adiposity, and these changes were asso-
ciated with increased hindgut fermentation and in-
creased circulating concentrations of satiety hormones
GLP-1 and PYY.
Methods
Diets
All diets during the study were purified, based on the
AIN-93 M diet (American Society for Nutrition,
Bethesda, MD, USA) for the maintenance of adult rats,
and were made and supplied by Special Diet Services Ltd,
Witham, Essex, UK (Table 1): The control diet contained
5% w/w cellulose (CONT), an additional control diet con-
tained 10% w/w cellulose (CELL), and the experimental di-
ets contained 10% w/w fructo-oligosaccharide (FOS), oat
beta-glucan (GLUC) or apple pectin (PECT) (Table 1).
During the final week before the experiment all rats were
habituated to the purified CONT diet.
Animals, experimental procedure and tissue collection
All animal experimental procedures conformed to the UK
Home Office Animal (Scientific Procedures) Act 1986, met
institutional and national guidelines for the care and use of
animals and were approved by local ethical review at the
University of Aberdeen Rowett Institute of Nutrition &
Health. The animal rooms were maintained at 21±2°C and
55 ±10% relative humidity, cages contained sawdust bed-
ding with shredded paper for nesting and plastic tunnels
for further enrichment, water was available ad libitum and
the lighting regime was a standard 12 h light, 12 h dark.
After 1 week acclimatisation to individual housing while
on CONT diet, young adult outbred male Sprague Dawley
rats (12 weeks old, 467±6.0 g; from Charles River Labora-
tories UK) were randomly allocated to weight-matched
groups and offered the pelleted experimental diets ad libi-
tum for 4 weeks (n=10/group). Voluntary food intake
was measured daily (by weighing food into the hopper and
weighing uneaten food 24 h later) and body weight was
measured twice a week. Body composition was measured
in conscious rats at the start (0 week) and end (4 weeks)
of the experiment by magnetic resonance imaging (MRI;
EchoMRI 2004, Echo Medical Systems, Houston, TX,
USA), which measures the masses of fat and lean tissues
in live animals using nuclear magnetic resonance (NMR)
technology (validated in [28,29]): the fat reading includes
all of the fat molecules in the body expressed as equivalent
weight of canola oil, and the lean reading is a muscle mass
equivalent of all the body parts containing water, exclud-
ing fat, bone and substances that do not contribute to the
NMR signal such as hair and claws.
Table 1 Composition of experimental diets
1
Diet
CONT CELL FOS GLUC PECT
Ingredients (% w/w)
Maize starch 46.57 41.57 41.57 41.57 41.57
Maltodextrin 15.5 15.5 15.5 15.5 15.5
Sucrose 10 10 10 10 10
Casein 14 14 14 14 14
Soyabean oil 4 4 4 4 4
AIN-93 Mineral mix 3.5 3.5 3.5 3.5 3.5
AIN-93 Vitamin mix 1 1 1 1 1
Choline bitartrate 0.25 0.25 0.25 0.25 0.25
L-cystine 0.18 0.18 0.18 0.18 0.18
Cellulose 5 10 0 0 0
FOS
2 00 1 000
Beta-glucan
3 0001 0 0
Pectin
4 0000 1 0
ME
5 (MJ/kg) 15.7 15.2 15.2 15.2 15.2
GE
6 (MJ/kg) 17.2 17.4 17.2 17.1 17.1
Composition (% w/w)
Dry matter 91.9 92.2 92.2 91.9 92.0
Total carbohydrate
7 63.5 58.5 59.5 65.3 57.5
Total nitrogen
8 2.0 2.0 2.0 2.1 2.1
Total fat
9 4.5 5.0 5.2 4.7 4.7
NSP
10- soluble 0.50 0.46 8.78
11 7.74
12 4.23
NSP
10- insoluble 2.02 3.45 0.45 0.46 0.62
1All diets were based on AIN-93 M diet (American Society for Nutrition,
Bethesda, MD USA) and manufactured by Special Diet Services Ltd. (Witham,
Essex UK).
2Fructo-oligosaccharide (Higher Nature FOS Powder; Revital Ltd., Ruislip,
Middlesex UK).
3Oat beta-glucan (Cambridge Commodities Ltd., Ely, Cambridgeshire UK).
4Apple pectin (Solgar Apple Pectin; Revital Ltd.).
5ME, metabolisable energy calculated from Atwater Fuel Energy of
diet components.
6GE, gross energy determined using Gallenkamp Adiabatic Bomb Calorimeter.
7Total carbohydrate by standard acid-hydrolysis followed by colorimetric
glucose determination.
8Total nitrogen determined using VarioMax CN Analyser.
9Total fat measured using standard acid-hydrolysis and gas chromatography.
10NSP, non-starch polysaccharides, analysed by the Englyst procedure [27],
using gas chromatography and spectrophotometry to measure constituent
sugars, and including
11fructose detection for FOS diet by ultra performance liquid chromatography.
12GLUC diet analysed specifically for beta-glucan by assay kit (K-BGLU;
Megazyme, Bray, Co. Wicklow, Ireland).
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capitation under general inhalation anaesthesia (isoflurane;
IsoFlo®, Abbott Animal Health, Maidenhead, Berkshire,
UK), approximately 1-3 h after lights on. Final (trunk)
blood samples were collected into chilled tubes containing
EDTA as anti-coagulant and a peptidase inhibitor cocktail
containing general protease inhibitor (cØmplete; Roche
Diagnostics Ltd, Burgess Hill, West Sussex, UK) and
dipeptidyl peptidase-4 inhibitor (Ile-Pro-Ile; Sigma), cen-
trifuged immediately at 3000 g for 10 min, then plasma
was stored at -20°C until analysis. The gut was dissected
out for sampling the contents from caecum and colon
and tissue from distal ileum and proximal colon. Cae-
cum and colon contents were stored at -20°C until ana-
lysis. Tissue samples were immersed in RNAlater
(QIAGEN, Crawley, UK) for 5 days at 4°C and then
stored at -80°C until analysis.
Plasma analyses
Plasma samples were analysed by commercial radio-
immunoassay kits according to the manufacturers’ instruc-
tions. Total GLP-1 was measured by kit GLP1T-36HK
(Merck Millipore, Billerica, MA, USA; lower detection limit
3 pM) which detects all forms of GLP-1, and active GLP-1
was measured by kit GLP1A-35HK (Merck Millipore; lower
detection limit 3 pM) which detects only the biologically
active form of GLP-1, i.e. GLP-1(7-36) amide or GLP-1
(7-37). PYY was measured by kit RMPYY-68HK (Merck
Millipore; lower detection limit 15.6 pg/ml), which de-
tects both of the circulating biologically active forms of
PYY, namely PYY(1-36) and PYY(3-36). Total ghrelin was
measured by kit RK-031-31 (Phoenix Pharmaceuticals Inc.,
Burlingame, CA, USA; detection range 10-1280 pg/ml)
which detects the combined octanoylated (bioactive)
and des-octanoylated forms, and bioactive CCK (26-33)
(non-sulfated) was measured by kit RK-069-04 (Phoenix
Pharmaceuticals Inc.; detection range 10-1280 pg/ml).
Analysis of fermentation products
The concentrations of SCFA and other organic acids pro-
duced by bacterial fermentation in caecum and colon con-
tents were determined by capillary gas chromatography
using the method developed by Richardson et al. [30].
Briefly, samples were diluted with distilled water (1/4) and
2-ethylbutyric acid (5 mmol/L) was added as internal stand-
ard. Samples were then extracted in diethyl ether, derivatised
with N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide
and analysed on Agilent GC HP-1 capillary columns. This
method detects formate, acetate, propionate, butyrate, iso-
butyrate, valerate, iso-valerate, lactate and succinate.
RNA isolation and real-time qPCR
Total RNA was extracted from the gut tissue samples
using RNeasy® Mini Kit (QIAGEN, Crawley, UK). Briefly,
weighed samples were homogenised using Zirconia
beads (BioSpec, Bartlesville, USA) and a Precellys®24
bead-based homogeniser (Bertin Technologies, Ann
Arbor, USA), the homogenates were centrifuged in
RNeasy spin columns and on-column DNase digestion
was conducted before eluting the RNA. Total RNA was
quantified by measuring the absorbance at 260 nm using
a NanoDrop spectrophotometer and purity assessed by
measuring the ratio of absorbance at 260 and 280 nm.
Overall quality was also assessed using an Agilent Bioa-
nalyzer (Agilent Technologies, Santa Clara, USA) and all
samples had RIN values >8.9. RNA was then stored
at -80°C. The synthesis of cDNA from the RNA was
carried out using a high capacity cDNA kit and com-
pleted using a GeneAmp® PCR System 9700 thermal cycler
(both from Applied Biosystems, Warrington, UK).
Relative gene expression analysis was carried out in line
with the Minimum Information for Publication of Quanti-
tative Real-Time PCR Experiments (MIQE) guidelines [31].
Initially, the expression of three candidate reference genes
β-actin (beta-actin), B2M (beta-2-microglobulin) and Tbp
(TATA box binding protein), together with ffar2, was
determined by qPCR using a 7500 Fast Realtime PCR
System (Applied Biosystems). B2M had the closest level
of expression and similar PCR efficiency to ffar2 and
was therefore chosen as the most appropriate reference
gene for this study. Commercially available PCR primers
were used (QIAGEN, Crawley, UK) for Tbp (reference #
QT01605632), β-actin (QT00193473), B2M (QT00176
295), ffar2 (QT00384860), ffar3 (QT01299144), sucnr1
(QT00454496), GLP-1 (QT00192661), and PYY (QT02
352637). RNA abundance was measured by qPCR with a
7500 Fast Realtime PCR System (Applied Biosystems)
using the SYBR green detection method.
Statistics
Daily food intakes and twice weekly body weight data
were analysed by repeated measures ANOVA (General
Linear Model with time, diet and their interaction as fac-
tors; Minitab version 16, Minitab Inc., State College,
PA). Cumulative food intake, initial and final MRI data,
changes in body weight, fat mass and lean mass during
the experiment and final plasma hormone concentra-
tions were analysed by one-way ANOVA (Minitab). Pair-
wise group comparisons were then made by the Tukey
method. Pearson’s product–moment correlation was
used to examine the relationships between food intake
and bodyweight gain, changes in fat and lean mass, and
plasma gut satiety hormone concentrations (Minitab).
For qPCR data, group-wise comparisons of gene expres-
sion ratios were performed using the public domain pro-
gram Relative Expression Software Tool (REST; http://
www.gene-quantification.info/) [32]. The gene expres-
sion values were normalised to the reference gene
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levels relative to the level in the CONT group. Overall,
P values of 0.05 or less were considered to be statisti-
cally significant.
Results
Food intake, body weight and body composition
For daily food intake, repeated measures ANOVA re-
vealed highly significant effects of diet, time and their
interaction (all P <0.001; Figure 1a). There were no dif-
ferences between CONT and CELL group daily intakes at
any time point. GLUC, FOS and PECT groups all had
lower daily intakes than the CONT group (the primary
control group given 5% w/w insoluble fibre), with the dif-
ferences being greatest during the first week but nonethe-
less present throughout the experiment (Figure 1a).
Compared with the CELL group (the additional control
group given 10% w/w insoluble fibre), daily intakes were
significantly lower throughout (P<0.001-0.05) in the
GLUC group from day 2 and in FOS and PECT groups
from day 1 (Figure 1a). Cumulative intake was significantly
lower for rats fed GLUC (P<0.05), FOS and PECT (both
P<0.001) than CONT and CELL, with no significant dif-
ference between CONT and CELL groups nor between
GLUC, FOS and PECT groups (Table 2). Repeated mea-
sures ANOVA revealed significant effects on body weight
of time (P<0.001) and diet group (P<0.01) with order of
decreasing magnitude CELL>CONT>GLUC>FOS>
PECT (Figure 1b). In view of the divergence in body
weight between the groups, MRI values for total fat and
lean mass are expressed as a percentage of the final body
weight. Initial percentage total fat and lean were not differ-
ent between the groups (Table 2). Compared with CONT,
overall body weight gain was lower in GLUC (P<0. 01 ),
FOS (P<0. 01 ) an d PE CT (P<0.001) groups, body fat
mass gain was lower in GLUC, FOS and PECT (all P<
0.001) but there was no difference in lean tissue mass gain
(Table 2); differences in final body weight did not reach
significance, final percentage total body fat was lower in
GLUC (P<0. 05 ), FO S (P<0.01) and PECT (P<0.001)
groups, and final percentage total lean tissue was higher in
FOS (P<0. 05 )a ndPE CT(P<0.01) groups (Table 2). Per-
centage total lean tissue was also greater in PECT than
GLUC groups (P<0.05), but there were no differences in
fat or lean (changes in absolute mass or final percentage
values) between CONTand CELL groups.
Across all groups (n= 50) there were highly significant
correlations between cumulative food intake and body
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Figure 1 Food intakes and body weights. (a) Daily voluntary food intake and (b) twice weekly body weights in rats given diets containing
different dietary fibres for 4 weeks. Diets contained 5% w/w cellulose (CONT) or 10% w/w fibre as cellulose (CELL), oat beta-glucan (GLUC),
fructo-oligosaccharide (FOS) or apple pectin (PECT). Values are means±s.e.m. (n=10/group). Data analysed by repeated measures ANOVA.
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a weaker correlation with lean tissue gain (P <0. 01 )
(Figures 2a-c).
Plasma satiety hormone concentrations
Plasma concentrations of PYY and total GLP-1 were ele-
vated in GLUC, FOS and PECT groups compared with
CONT (all P<0.001), and GLUC rats had lower PYY than
FOS and PECT groups (both P<0.05) and lower total
GLP-1 than FOS rats (P<0.05) (Figure 3a,b); there were
no differences between CELL and CONT groups. There
were no differences between any of the groups for active
GLP-1, CCK or ghrelin concentrations (Figure 3c-e).
Across all groups (n=50) there were highly significant
correlations between cumulative food intake and plasma
concentrations of total GLP-1 (r=0. 51 6 , P<0. 00 1) an d
PYY (r=0. 62 3,P<0.001).
Concentrations of fermentation products in caecum and
colon contents
Total concentrations of fermentation products were sig-
nificantly greater in the caecum of FOS, GLUC and
PECT groups than CONT or CELL groups, greater in
the colon of FOS and GLUC than CONT and CELL
groups, and greater in the colon of PECT than CELL
group (P <0.05-0.001; Table 3). The main fermentation
products detected were acetate, propionate, butyrate and
succinate; lactate concentrations were low and were not
significantly different between groups in caecum or
colon, and concentrations of formate, iso-butyrate, valer-
ate and iso-valerate were minimal (not reported). In cae-
cal contents, compared with CONT, the FOS group had
higher succinate (P <0.001), lower acetate (P <0.001)
and lower propionate (P<0.01), GLUC had higher suc-
cinate (P <0.001) and lower acetate (P <0.001), PECT
had higher succinate (P <0.01) and the CELL group was
not different (Table 3). Butyrate concentrations did not
differ from CONT, but were lower in PECT than FOS
group (P <0.01). Succinate was higher (P <0.01) and
acetate was lower (P <0.001) in FOS and GLUC groups
than in the PECT group. Similar group differences were
seen in colonic contents where, compared with CONT,
the FOS group had higher succinate (P<0.001) and
lower acetate (P < 0.001), GLUC had higher succinate
Table 2 Cumulative food intake and changes in body weight and body composition
1 in rats given different dietary
fibres for 4 weeks
Diet group
2
CONT CELL FOS GLUC PECT
Cumulative food intake (g) 543.5
a ±22.8 566.2
a± 16.1 448.6
b±15.1 488.5
b ±16.5 442.5
b±10.5
Body weight gain (g) 93.6
a±8.23 87.0
a ±8.43 59.0
b± 5.39 59.3
b±6.27 51.5
b± 6.77
Body fat gain (g) 20.6
a±3.41 16.7
a ±3.81 -0.15
b±2.07 2.25
b±1.78 -9.31
b±2.94
Lean tissue gain (g) 59.0±5.22 59.4±4.17 49.8±4.34 41.3± 8.06 55.8±4.91
Initial total body fat (%) 8.22±0.63 7.60±0.76 7.81±0.57 8.21± 0.59 8.71±0.87
Initial total body lean (%) 80.1±0.63 80.5±0.72 80.1±0.65 80.1± 0.60 79.2±0.87
Final total body fat (%) 10.4
a±0.86 9.26
a ±1.03 6.81
b± 0.73 7.71
b±0.58 6.08
b± 0.46
Final total body lean (%) 77.5
a±0.93 78.7
a ±0.96 80.7
b± 0.81 79.1
a,b± 1.35 82.1
b± 0.43
1Total body fat mass and lean tissue mass measured by MRI.
2Diets were control (CONT, 5% w/w cellulose) or contained 10% w/w fibre as cellulose (CELL), fructo-oligosaccharide (FOS), oat beta-glucan (GLUC) or apple pectin
(PECT); n =10/group. Values are mean ± s.e.m. Within rows, values without a common letter are significantly different (P< 0.05).
r = 0.748***
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Figure 2 Correlations between food intake and body weight and composition. Relationships with cumulative food intake for (a) body weight
gain, (b) total fat mass gain and (c) total lean mass gain for rats given diets containing different dietary fibres for 4 weeks. Diets contained 5% w/w
cellulose (CONT, open circles) or 10% w/w fibre as cellulose (CELL, very light grey squares), oat beta-glucan (GLUC, light grey circles), fructo-oligosaccharide
(FOS, dark grey triangles) or apple pectin (PECT, solid squares). **P<0.01, ***P<0.001;r, Pearson product–moment correlation coefficient.
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succinate (P< 0.001) and the CELL group was not different
(Table 3). There were no differences in colonic butyrate
concentrations, but succinate was higher (P< 0.001) and
acetate was lower (P<0.01) in FOS and GLUC groups than
in the PECTgroup.
Gene expression for SCFA and succinate receptors and for
satiety hormones in ileum and colon tissue
Relative to CONT group, ffar2 gene expression was in-
creased in the distal ileum of the FOS group (P<0.01;
Table 4); ffar3 gene expression was decreased in prox-
imal colon of FOS and PECT groups (P <0.05-0.01);
sucnr1 gene expression was increased in distal ileum
and proximal colon of CELL group (P <0.05-0.01); GLP-
1 gene expression was decreased in distal ileum of PECT
group (P <0.05); PYY gene expression was decreased in
distal ileum of PECT group and in proximal colon of
CELL group (P <0.05); and relative expression of all
other gene/tissue combinations was not significantly dif-
ferent (Table 4).
Discussion
This experiment has shown how three very different sol-
uble fermentable dietary fibres, beta-glucan, FOS and
pectin, all similarly decreased voluntary food intake,
weight gain and adiposity in normal healthy young adult
male rats over a 4-week period, and the associated in-
creased plasma concentrations of PYY and GLP-1 were
strongly indicative of increased satiety. While these data
demonstrate an animal model of fibre-induced satiety,
the dietary inclusion rate (10% w/w, or 6.6 mg/kJ) was
approximately twice the US recommended daily fibre in-
take of 3.3 mg/kJ for men [33,34] and further work is re-
quired to translate the findings to humans.
Whereas 10% w/w insoluble fibre cellulose had no ef-
fect on food intake compared with the control group,
the same inclusion rate of the three soluble dietary fibres
each had similar effects, decreasing cumulative intake by
10-19% over 4 weeks and daily intakes by ~12% after an
initial week of adjustment. Although the immediate de-
creases in intake following introduction of the high fibre
diets may have reflected some initial unfamiliarity and low
palatability to the rats, the consistently lower daily intakes
thereafter once they had become accustomed to the diets
were more likely indicative of increased satiety since they
were associated with increased circulating concentrations
of two important satiety hormones. The three soluble diet-
ary fibres specifically increased concentrations of total
GLP-1 and PYY in plasma samples taken in the early part
of the light phase at the end of the trial, indicative of raised
tonic secretion of these hormones, and the magnitude of
the increases were similar to those associated with in-
creased satiety in other rat models [16,35]. Predictably,
changes in active GLP-1 were not detected since it only
has a 1-2 minute half-life and samples were not taken im-
mediately after feeding episodes; nonetheless, measure-
ment of total GLP-1 includes both the intact hormone
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Figure 3 Plasma hormone concentrations. Plasma concentrations of (a) PYY, (b) total GLP-1, (c) active GLP-1, (d) CCK and (e) ghrelin in rats
given diets containing different dietary fibres for 4 weeks. Diets contained 5% w/w cellulose (CONT) or 10% w/w fibre as cellulose (CELL), oat
beta-glucan (GLUC), fructo-oligosaccharide (FOS) or apple pectin (PECT). Values are means±s.e.m. (n=10/group). Significant differences were
detected by one-way ANOVA. *P<0.05, ***P<0.001 vs CONT, unless indicated.
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http://www.nutritionandmetabolism.com/content/11/1/36and its primary metabolite and thereby provides an accur-
ate indication of overall GLP-1 secretion [36]. Tonic
plasma concentrations of ghrelin and CCK were un-
changed. This was perhaps not surprising since ghrelin is
secreted in the stomach and CCK is produced by I-cells
that are located mainly in the duodenum and jejunum
whereas the presence of indigestible dietary fibre in the
gut is most likely to be detected nearer to where it is fer-
mented in the large intestine. In line with this argument,
PYY and GLP-1 are both secreted from L-cells situated
mainly in the distal small intestine and proximal large in-
testine [18]. Our data are consistent with findings in rats
fed dietary resistant starch where total GLP-1 and PYY
were up-regulated in a sustained day-long manner
through fermentation [35]. It is inferred that significant
satiety-inducing effects of dietary fibre only manifest them-
selves after several days of consistently increased fibre in-
take and it is tempting to speculate that this reflects a
m i n i m u me x p o s u r et i m ef o rt h eu n d e r l y i n gc h r o n i c
changes in the gut environment and in tonic gut satiety
hormone secretion to develop.
The reductions in food intake on the three diets con-
taining soluble fermentable fibre were associated with
significant reductions in body weight gain and it is note-
worthy that this was attributable to the arrested accumu-
lation of fat with lean tissue growth maintained. Both
body weight gain and fat mass gain were closely corre-
lated with the cumulative food intake (Figure 2). These
Table 3 Concentrations (mmol/l) of fermentation products in caecum and colon contents of rats given different dietary
treatments
Diet group
1
CONT CELL FOS GLUC PECT
Caecum
Concentrations (mmol/l)
Total 68.9±7.01
a 61.2±7.79
a 115.9± 10.80
b,c 131.7±6.82
c 97.7±6.88
b
Acetate 47.6±2.72
a 41.2±3.14
a 21.7± 3.51
b 23.8±3.38
b 49.2±6.00
a
Propionate 8.6± 0.58
a,b 6.7± 0.48
b,c 4.0± 0.89
c 11.9±1.88
a 7.8±0.70
b,c
Butyrate 7.1± 0.58
a,b 8.0±1.37
a,b 10.3± 2.29
a 7.5 ±1.48
a,b 3.9±0.84
b
Succinate 5.3±4.70
a 6.2±3.52
a 74.2±11.03
b 88.5±8.93
b 36.8± 7.14
c
Lactate 1.3 ±0.92 0.0 5.7± 4.64 0.0 0.0
Proportional concentrations
Acetate 0.69 0.67 0.19 0.18 0.50
Propionate 0.12 0.11 0.03 0.09 0.08
Butyrate 0.10 0.13 0.09 0.06 0.04
Succinate 0.08 0.10 0.64 0.67 0.38
Lactate 0.02 0.00 0.05 0.00 0.00
Colon
Concentrations (mmol/l)
Total 63.5± 6.53
a,b 52.0±6.51
b 121.3±4.51
c 131.0±5.41
c 79.7±8.63
a
Acetate 40.9±4.59
a 33.4±2.96
a 15.7± 1.85
b 16.4±3.46
b 32.4±3.97
a
Propionate 7.7 ±0.77 6.4±0.74 3.6± 0.99 5.0±1.50 6.6±1.20
Butyrate 5.6 ±0.82 8.2±3.08 5.4± 1.30 5.3±1.74 2.9±0.70
Succinate 6.7±3.41
a 3.0±0.80
a 92.0± 9.35
b 104.3± 6.73
b 37.8± 8.70
c
Lactate 2.6 ±1.98 1.0±0.79 4.6± 3.87 0.0 0.0
Proportional concentrations
Acetate 0.64 0.64 0.13 0.13 0.41
Propionate 0.12 0.12 0.03 0.04 0.08
Butyrate 0.09 0.16 0.04 0.04 0.04
Succinate 0.11 0.06 0.76 0.80 0.47
Lactate 0.04 0.02 0.04 0.00 0.00
1Diets were control (CONT) or contained 10% w/w fibre as cellulose (CELL), fructo-oligosaccharide (FOS), oat beta-glucan (GLUC) or apple pectin (PECT). Values are
means ± s.e.m. (n = 10/group). Within rows, values without a common letter are significantly different (P< 0.05).
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existing reports of dietary oat beta-glucan decreasing
epididymal fat pad weights in growing rats [10] and of
dietary FOS decreasing fat pad mass in rats [10,13] and
lend support to the notion that fermentable dietary fibre
has potential as a tool for body weight and body fat
regulation through its effects on satiety. While differ-
ences in eating behaviour, physical activity and heat ex-
penditure (from increased fermentation) may also have
contributed to the observed differences between the sol-
uble fibre-fed rats and controls, the overall outcome was
a similar decrease in food intake, body weight and body
fat in all three soluble fibre-fed groups.
Soluble dietary fibres may influence satiety by virtue of
their physicochemical properties, for example those with
high viscosity such as pectin and beta-glucan tend to
slow the rate of gastric emptying and overall gut transit
time, which can lead to reduced intakes [10,14,15]. How-
ever the present intake responses were also shown with
FOS, which has negligible viscosity [10]. The common
feature of the three fibres studied herein was their fer-
mentability in the large intestine, resulting in greatly in-
creased total concentrations of fermentation products in
the caecum and colon contents. The highest concentra-
tion was that of succinate, whereas dietary studies in the
literature appear rarely to report succinate concentra-
tions, concentrating rather on the main three SCFAs.
Succinate is produced by intestinal bacterial species of
the Bacteroides and Clostridium genera [21], numbers of
Bacteroides have been shown to increase in rats given
dietary inulin and FOS [37] and increased caecal succin-
ate concentrations of comparable magnitude to those re-
ported herein have previously been reported in rats
given 6% FOS [38] or 5% pectin [39]. It appears from
these latter studies and from the present one that the
production of large amounts of succinate is favoured
when rats are given a rapidly soluble and fermentable
fibre source in a purified diet and when the protein
source is a highly digestible one such as casein; this is
thought to be because a lack of nitrogen relative to the
carbohydrate availability in the large intestine promotes
high succinate concentrations [38]. Moreover, succinate
is absorbed by the intestinal mucosa more slowly than
other SCFAs [40], which would lead to its relative accu-
mulation. However, it is unlikely that the increased suc-
cinate per se elicited the satiety response in our model
since succinate concentrations were lower in PECT than
GLUC or FOS groups, yet the satiety response was simi-
lar. Furthermore, although increased luminal succinate
was associated with increased PYY and GLP-1 secretion
in the fermentable fibre-fed groups, there was no evi-
dence for increased succinate signalling to the gut enter-
oendocrine cells via its receptor sucnr1. Indeed, the only
increase in sucnr1 gene expression was unexpectedly
seen in the CELL group, in the absence of elevated lu-
minal succinate and without changes in PYY and GLP-1
secretion. It is unknown whether succinate activates the
SCFA receptors, ffar2 and ffar3 [41].
After succinate, in terms of relative concentrations,
acetate was the dominant fermentation product in all
three fermentable fibre groups, but whereas concentra-
tions of propionate were greater than butyrate in PECT
and GLUC groups, the reverse was observed in the FOS
group. The differences in fermentation products between
the soluble fibres may reflect different patterns of fer-
mentation and/or different rates of fermentation and
turnover, which the present measurements at a single
time point would not have detected. Nonetheless, given
the similar levels of satiety observed in all groups, it is
hard to attribute relevance of these SCFA differences to
signalling satiety.
It was perhaps surprising that there were no increases
in concentrations of the main three SCFAs in caecum
Table 4 Gene expression in distal ileum and proximal
colon for experimental diet groups relative to control
(CONT) group
Gene
1 Group
2 Gene expression
3
Distal ileum Proximal colon
ffar2 CELL 1.16 (0.12-5.16) 1.24 (0.20-3.14)
FOS 2.15 (0.73-7.05)** 1.02 (0.33-3.10)
GLUC 1.07 (0.33-3.81) 1.07 (0.43-2.97)
PECT 1.23 (0.42-7.31) 0.63 (0.13-2.48)
ffar3 CELL 1.40 (0.15-14.72) 0.68 (0.14-3.58)
FOS 1.11 (0.21-9.44) 0.42 (0.06-2.39)*
GLUC 0.49 (0.02-4.91) 0.63 (0.10-7.68)
PECT 1.15 (0.13-11.39) 0.42 (0.09-1.85)**
sucnr1 CELL 3.59 (0.17-33.62)* 4.13 (0.47-52.44)**
FOS 0.70 (0.03-11.53) 0.82 (0.06-8.85)
GLUC 1.75 (0.06-23.59) 1.65 (0.11-56.72)
PECT 0.95 (0.01-16.54) 0.79 (0.04-14.45)
GLP-1 CELL 0.81 (0.34-2.01) 0.71 (0.13-4.48)
FOS 0.79 (0.23-1.93) 1.54 (0.35-9.73)
GLUC 0.78 (0.35-1.69) 1.82 (0.43-10.01)
PECT 0.53 (0.03-1.71)* 1.18 (0.15-8.77)
PYY CELL 0.97 (0.46-2.50) 0.62 (0.30-1.32)*
FOS 0.91 (0.24-2.74) 0.78 (0.32-3.71)
GLUC 0.79 (0.32-2.16) 1.11 (0.30-3.18)
PECT 0.40 (0.00-1.75)* 0.71 (0.11-2.70)
1Abbreviations are: ffar free fatty acid receptor, sucnr succinate receptor, GLP-1
glucagon-like peptide-1, PYY peptide tyrosine tyrosine.
2Groups were given diets containing 10% w/w fibre as cellulose (CELL),
fructo-oligosaccharide (FOS), oat beta-glucan (GLUC) or apple pectin
(PECT); n =10/group.
3Values are medians (with 95% C.I.) as determined by REST-2009 [32].
*P <0.05, **P < 0.01.
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pared with controls, and indeed concentrations were un-
expectedly lower for acetate in FOS and GLUC groups
and for propionate in the FOS group. There may be a
number of reasons for this, apart from the overwhelming
dominance of the succinate: for example, measuring con-
centrations at a single time point would have given no in-
dication of biologically significant changes in rates of
turnover. Nonetheless, the volume of contents and hence
the total pool of SCFAs would have been increased in the
fermentable fibre groups because the large intestine was
visibly enlarged. This observation was supported by mea-
surements of increased caecum and colon weights in rats
given 10% PECT in a separate experiment (Adam et al.,
unpublished results) and is in agreement with published
data on rats fed the dietary fibre inulin [42]. Although the
caecum is the primary site for dietary fibre fermentation,
SCFA concentrations and group differences were similar in
colon and caecum contents. There was also visible leakage
of caecal contents back into the distal ileum, indicating that
enteroendocrine L-cells in both the distal ileum and prox-
imal colon would have been exposed to SCFAs, from where
satiety responses may have been elicited, and a recent re-
port indicates that L-cell numbers are fairly evenly distrib-
uted along the rat jejunum, ileum and colon [43].
Whereas a recent review concludes overall that SCFAs
may not play a role in appetite regulation [44], in vitro
evidence shows that they can trigger GLP-1 release from
cultured colonic L-cells via the SCFA receptors ffar2 and
ffar3 [25] and stimulate GLP-1 (proglucagon) mRNA ex-
pression in cultured enteroendocrine STC-1 cells [35].
Some in vivo evidence indicates that oral administration
of butyrate or propionate decreases food intake and bu-
tyrate stimulates GLP-1 and PYY secretion in mice, but
these were ffar3-deficient animals indicating that ffar3 is
not involved in SCFA stimulation of these gut satiety
hormones [45]. The present data are consistent with this
since we found no evidence for increased ffar3 gene ex-
pression and indeed there was even a decrease in ex-
pression in the proximal colon of FOS and PECT groups
(Table 4). Similarly we found little evidence for increased
gene expression for ffar2, the one exception being an in-
crease in the distal ileum of FOS-fed rats. The absence
of increased gene expression found here for PYY and
GLP-1 in distal ileum and proximal colon, despite the
greatly increased plasma concentrations of these hor-
mones, was another apparently anomalous finding and
gene expression for both was even decreased in the
PECT group. Since PYY and GLP-1 are secreted from in-
testinal L-cells, the increased plasma concentrations
must reflect either increased secretory activity per cell or
increased number of L-cells. The apparent anomalies are
most likely attributable to an overall increase in L-cell
number along the enlarged intestines, which was not
detectable here since the real time PCR method mea-
sures expression per mg tissue. The same PECT diet
given for 4 weeks to adult male rats in a separate experi-
ment increased the weights and lengths of both colon
and small intestine (Adam et al., unpublished results).
This is not without precedent since a doubling of the L-
cell population in the rat intestinal mucosa occurs with
no change in L-cell density due to general gut hyper-
trophy both after Roux-en-Y gastric bypass and in the
Zucker Diabetic Fatty rat model [43,46]. These authors
also report increased plasma GLP-1 concentrations in
their models, associated with the increased L-cell num-
ber and overall increased proglucagon (GLP-1) gene ex-
pression (by in situ hybridisation) without any increase
in gene expression per cell. Other reports of increased
L-cell differentiation and number in the proximal colon
of rats fed fermentable indigestible carbohydrate lend
support to this argument [13,23]. Altogether the present
data are consistent with increased circulating PYY and
GLP-1 concentrations arising from overall increased
numbers of L cells along the ileum and colon exposed to
increased amounts of fermentation products, but further
mechanistic investigations need to acknowledge the po-
tential influence of gut hypertrophy in this model.
Conclusions
These data show that sustained daily intake of diverse
types of soluble dietary fibre increases satiety and de-
creases overall food intake, weight gain and adiposity, as-
sociated with increased circulating GLP-1 and PYY and
increased hindgut fermentation. Moreover it appears
that the presence of soluble fibre is more important than
the source of soluble fibre for reducing diet intake and
body weight gain. Therefore, the study demonstrates an
animal model of dietary fibre-induced satiety that may
be used for further investigation of underlying mecha-
nisms and provides proof of principle worthy of investi-
gation in humans towards a natural means of body
weight regulation.
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